-
China’s NBS Manufacturing PMI contracts to 49.5 in September vs. 50.2 expected
China’s official Manufacturing Purchasing Managers’ Index (PMI) unexpectedly contracted in October, arriving at 49.5 when compared to the 50.2 expansion in September, the latest data published by the country’s National Bureau of Statistics (NBS) showed on Tuesday. The market consensus was for a 50.2 figure. The index dropped back below the 50 mark, which separates…
-
China’s JD Revealed as Partner in Hillhouse $255M Singapore Industrial Buy
Frank Ng and the EZA Hill team worked with JD Property for the portfolio buy China’s JD Property has teamed up with a start-up real estate investment firm backed by Hillhouse Capital with the partners having set up an operating platform in Singapore after acquiring five logistic properties in the city-state, according to an announcement…
-
China’s top diplomat Wang Yi to pay rare US visit ahead of potential Xi trip
WASHINGTON: China’s top diplomat will pay a rare visit to Washington this week, the United States announced Monday (Oct 23), paving the way for a potential visit by President Xi Jinping aimed at keeping tensions in check. Foreign Minister Wang Yi, the highest-ranking Chinese official in the US capital in nearly five years, will visit…
-
Li Keqiang, China’s top economic official for a decade, dies at 68
BEIJING — Former Premier Li Keqiang, China’s top economic official for a decade, died Friday of a heart attack. He was 68. Li was China’s No. 2 leader from 2013-23 and an advocate for private business but was left with little authority after President Xi Jinping made himself the most powerful Chinese leader in decades…
-
CHINABANG Awards 2023: Nominations for China’s Overseas New Power List and Discover China’s Pioneering Innovators on the Global Stage
Since its inception in 2011, the CHINABANG Awards has been dedicated to identifying and nurturing the power of innovation in China. Over the last decade, we have witnessed many innovative enterprises such as DiDi, Momo, DJI, Mobvoi, Ele. me, WeChat, and the Little Red Book evolved from humble beginnings to iconic symbols of China’s innovation…
-
China’s Detong Capital raises just over $200m for new RMB fund, eyes $274m final close
Shanghai-based private equity (PE) firm Detong Capital announced on Wednesday that it has raised over 1.5 billion yuan ($205.2 million) for its latest RMB-denominated fund, as the firm targets a final close of up to 2 billion yuan ($273.6 million). The new RMB fund, named “Changzhou Detong Hexin II Venture Capital Partnership (Detong Hexin II),”…
-
China’s AG600 amphibious aircraft expected to enter market in 2025
BEIJING, Feb. 17 (Xinhua) — China’s indigenously-developed AG600 large amphibious aircraft is expected to enter the market in 2025, according to the Aviation Industry Corporation of China (AVIC). AG600M aircraft, a model specialized for firefighting belonging to the AG600 large amphibious aircraft family, will aim to obtain the type certificate in 2024, said the AVIC,…
-
China’s Top Diplomat to Skip U.N. Assembly, Raising Doubts About Possible Xi Visit to U.S.
China’s Top Diplomat to Skip U.N. Assembly, Raising Doubts About Possible Xi Visit to U.S. Subscribe Sign In SubscribeSign In Edition Print Edition Video Audio Latest Headlines More Edition Print Edition Video Audio Latest Headlines More China’s Top Diplomat to Skip U.N. Assembly, Raising Doubts About Possible Xi Visit to U.S. Read More
-
China’s Economy Grows 5.5% in First Half of 2023
On Monday, July 17, China’s National Bureau of Statistics released data indicating that the country’s economy demonstrated robust growth in the first half (H1) of 2023. Gross domestic product (GDP) reached RMB59.3034 trillion (about USD8.3 trillion), expanding by 5.5% compared to the same period last year, showing an increase of 1 percentage point. Examining the…
-
China’s Sinotau nets $152m to advance radiopharma pipeline ahead of IPO
Photo by Myriam Zilles on Unsplash Eudora Wang 03 July, 2023 Beijing Sinotau International Pharmaceutical Technology (Sinotau) has secured over 1.1 billion yuan ($151.8 million) in a new funding round to advance the R&D and clinical trials of its radiopharmaceutical pipeline, the firm announced on Monday. Edited by: Pramod Mathew Continue reading this premium story…